SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs is currently facing significant volatility as investors weigh strong quarterly growth against structural concerns regarding a new shelf offering that has created short-term selling pressure. The community remains deeply divided, with many long-term bulls highlighting the company's proprietary data advantage and defense sector momentum, while others are rotating capital in anticipation of the upcoming SpaceX IPO.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting investor attention as its decentralized cloud infrastructure and sovereign AI initiatives gain traction through real-world applications and government partnerships. Community sentiment remains polarized, with many retail holders focusing on long-term accumulation and staking rewards, while others express frustration over historical price volatility and broader crypto market correlation.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid intense community debate over leaked details of a potential ceasefire agreement with Iran and ongoing skepticism regarding the company's valuation. Traders are actively discussing the impact of these geopolitical negotiations and high-profile company events on the stock's long-term market performance.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors weigh disappointment over the Apple Intelligence rollout and Siri's limited international availability against the stock's resilience as a long-term core holding. The community is actively debating whether to buy the recent dip or if technical weakness and broader macro concerns, such as inflation data and upcoming IPO market activity, signal further downside.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is facing heavy selling pressure as investors react to management's warnings regarding industry-wide supply chain constraints, despite the company delivering strong earnings and raising its guidance. While the stock has seen a sharp pullback, the community is actively debating whether this is a structural weakness or a temporary 'buy the dip' opportunity for a foundational player in the AI data center infrastructure space.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending following the expansion of its AI credit-decisioning tools into the Buy Now, Pay Later space through a partnership with Upgrade, a move the community views as a strategic diversification of its revenue streams. While investors are debating the stock's valuation gap and volatility, active community sentiment remains focused on the company's sustained GAAP profitability and its potential to capture market share through AI-driven lending infrastructure.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin is drawing investor attention as the community debates the impact of ongoing token emissions versus potential catalysts like regulatory shifts and new mobile application launches. Discussions remain polarized, with many investors expressing frustration over price stagnation and supply dilution while others highlight the asset's underlying exchange utility and the recent emergence of native meme coins on the Cronos blockchain.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently drawing significant attention as investors react to positive Phase 3 results for its CRISPR-based HAE therapy and a subsequent public stock offering. The community is actively debating the impact of the dilution versus the company's strengthened long-term balance sheet, while many remain focused on the potential for a short squeeze given the high short interest.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending as investors monitor technical developments and potential consolidation patterns, with the community actively debating the company's debt management and its strategic memorandum of understanding with AMD. Market participants are focused on key resistance levels and potential institutional interest as the stock navigates a highly volatile, sentiment-driven environment.

Global X Funds - Global X Dow 30 Covered Call ETF

Global X Dow 30 Covered Call ETF

The Dow Jones Industrial Average is under intense scrutiny as investors weigh the ongoing geopolitical friction in the Strait of Hormuz against corporate earnings reports and shifting Federal Reserve policy. Market participants remain divided, with ongoing community debate centering on whether the recent rally is a sustainable trend or a fragile reaction to conflicting news regarding ceasefire negotiations and supply chain stability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buy

Promis Neurosciences (PMN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 231.8% in Promis Neurosciences (PMN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Promis Neurosciences (PMN) Projected to Post Quarterly Earnings on Monday

Promis Neurosciences (NASDAQ:PMN) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 4,000 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Patrick Kirwin purchased 4,000 shares of the stock in a transaction on Wednesday, April 22nd. The shares were bought at an average price...

Promis Neurosciences (NASDAQ:PMN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Promis Neurosciences (NASDAQ:PMN - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the four brokerages that are covering the stock, MarketBeat.com reports. One...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...

Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...

Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...

Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$1.46	--	--	N/A
Q1 '26	-$1.06	-$1.26	-18.87%	MISSED
Q4 '25	-$4.66	-$4.11	11.80%	BEAT
Q3 '25	-$0.29	-$6.00	-1968.97%	MISSED
Q2 '25	-$0.17	-$0.29	-66.76%	MISSED

PMNProMIS Neurosciences

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings

Latest PMN News